The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
Rakesh Sharma, BSc, MRCP*,
Mathias Rauchhaus, MD* ,
Piotr P. Ponikowski, MD, PhD*,
Susan Varney, BSc*,
Philip A. Poole-Wilson, MD, FACC*,
Douglas L. Mann, MD, FACC ,
Andrew J. S. Coats, DM, FACC* and
Stefan D. Anker, MD, PhD*
* Department of Cardiac Medicine, National Heart & Lung Institute, Imperial College School of Medicine, London, United Kingdom
Department of Medicine, Veterans Administration Medical Center, Baylor College of Medicine, Houston, Texas, USA
Franz-Volhard-Klinik (Charité, Campus Berlin-Buch) at Max-Delbrück-Centrum for Molecular Medicine, Berlin, Germany
Department of Internal Medicine III, Martin-Luther University, Halle, Germany

View larger version (15K):
[in a new window]
|
Figure 1 The correlation between ESR and soluble TNF receptor-1 plasma levels in 58 patients with CHF. CHF = chronic heart failure; ESR = erythrocyte sedimentation rate; sTNFR = soluble tumor necrosis factor receptor.
|
|

View larger version (22K):
[in a new window]
|
Figure 2 Kaplan-Meier survival plot for 159 patients with chronic heart failure. Patients were subgrouped according to erythrocyte sedimentation rate (ESR).
|
|
|